Angiography-Based Machine Learning for Predicting Fractional Flow Reserve in Intermediate Coronary Artery Lesions.

Journal: Journal of the American Heart Association
Published Date:

Abstract

Background An angiography-based supervised machine learning ( ML ) algorithm was developed to classify lesions as having fractional flow reserve ≤0.80 versus >0.80. Methods and Results With a 4:1 ratio, 1501 patients with 1501 intermediate lesions were randomized into training versus test sets. Between the ostium and 10 mm distal to the target lesion, a series of angiographic lumen diameter measurements along the centerline was plotted. The 24 computed angiographic features based on the diameter plot and 4 clinical features (age, sex, body surface area, and involve segment) were used for ML by XGBoost. The model was independently trained and tested by 2000 bootstrap iterations. External validation with 79 patients was conducted. Including all 28 features, the ML model with 5-fold cross-validation in the 1204 training samples predicted fractional flow reserve ≤0.80 with overall diagnostic accuracy of 78±4% (averaged area under the curve: 0.84±0.03). The 12 high-ranking features selected by scatter search were involved segment; body surface area; distal lumen diameter; minimal lumen diameter; length of a lumen diameter <2.0 mm, <1.5 mm, and <1.25 mm; mean lumen diameter within the worst segment; sex; diameter stenosis; distal 5-mm reference lumen diameter; and length of diameter stenosis >70%. Using those 12 features, the ML predicted fractional flow reserve ≤0.80 in the test set with sensitivity of 84%, specificity of 80%, and overall accuracy of 82% (area under the curve: 0.87). The averaged diagnostic accuracy in bootstrap replicates was 81±1% (averaged area under the curve: 0.87±0.01). External validation showed accuracy of 85% (area under the curve: 0.87). Conclusions Angiography-based ML showed good diagnostic performance in identifying ischemia-producing lesions and reduced the need for pressure wires.

Authors

  • Hyungjoo Cho
    Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • June-Goo Lee
    Biomedical Engineering Research Center, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, Korea.
  • Soo-Jin Kang
    Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Won-Jang Kim
    Department of Cardiology, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
  • So-Yeon Choi
    Department of Cardiology, Ajou University, Suwon, Korea.
  • Jiyuon Ko
    2 Biomedical Engineering Research Center Asan Institute for Life Sciences Seoul Korea.
  • Hyun-Seok Min
    1 Department of Cardiology University of Ulsan College of Medicine Asan Medical Center Seoul Korea.
  • Gun-Ho Choi
    1 Department of Cardiology University of Ulsan College of Medicine Asan Medical Center Seoul Korea.
  • Do-Yoon Kang
    Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Pil Hyung Lee
    Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Jung-Min Ahn
    Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Duk-Woo Park
    Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Seung-Whan Lee
    Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Young-Hak Kim
    Asan Medical Center, Seoul, Republic of Korea.
  • Cheol Whan Lee
    Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Seong-Wook Park
    Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
  • Seung-Jung Park
    Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.